Swiss National Bank’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-382,000
| Closed | -$1.57M | – | 2835 |
|
|
2022
Q1 | $1.57M | Buy |
382,000
+27,700
| +8% | +$114K | ﹤0.01% | 2170 |
|
|
2021
Q4 | $1.27M | Hold |
354,300
| – | – | ﹤0.01% | 2333 |
|
|
2021
Q3 | $1.29M | Buy |
354,300
+5,300
| +2% | +$19.3K | ﹤0.01% | 2311 |
|
|
2021
Q2 | $1.52M | Sell |
349,000
-12,800
| -4% | -$55.8K | ﹤0.01% | 2271 |
|
|
2021
Q1 | $1.49M | Buy |
361,800
+5,300
| +1% | +$21.8K | ﹤0.01% | 2172 |
|
|
2020
Q4 | $1.42M | Hold |
356,500
| – | – | ﹤0.01% | 2114 |
|
|
2020
Q3 | $963K | Buy |
356,500
+10,400
| +3% | +$28.1K | ﹤0.01% | 2108 |
|
|
2020
Q2 | $952K | Buy |
346,100
+45,400
| +15% | +$125K | ﹤0.01% | 2133 |
|
|
2020
Q1 | $710K | Buy |
300,700
+4,200
| +1% | +$9.92K | ﹤0.01% | 2006 |
|
|
2019
Q4 | $1.39M | Buy |
296,500
+6,700
| +2% | +$31.5K | ﹤0.01% | 1939 |
|
|
2019
Q3 | $969K | Buy |
289,800
+11,300
| +4% | +$37.8K | ﹤0.01% | 2075 |
|
|
2019
Q2 | $916K | Buy |
278,500
+20,100
| +8% | +$66.1K | ﹤0.01% | 2161 |
|
|
2019
Q1 | $783K | Buy |
258,400
+7,900
| +3% | +$23.9K | ﹤0.01% | 2199 |
|
|
2018
Q4 | $681K | Buy |
+250,500
| New | +$681K | ﹤0.01% | 2223 |
|
|
2015
Q4 | – | Sell |
-196,300
| Closed | -$334K | – | 2664 |
|
|
2015
Q3 | $334K | Buy |
196,300
+29,900
| +18% | +$50.9K | ﹤0.01% | 2361 |
|
|
2015
Q2 | $346K | Buy |
166,400
+21,600
| +15% | +$44.9K | ﹤0.01% | 2404 |
|
|
2015
Q1 | $392K | Hold |
144,800
| – | – | ﹤0.01% | 2296 |
|
|
2014
Q4 | $372K | Buy |
144,800
+7,500
| +5% | +$19.3K | ﹤0.01% | 2329 |
|
|
2014
Q3 | $251K | Hold |
137,300
| – | – | ﹤0.01% | 2386 |
|
|
2014
Q2 | $367K | Hold |
137,300
| – | – | ﹤0.01% | 2313 |
|
|
2014
Q1 | $481K | Buy |
137,300
+28,200
| +26% | +$98.8K | ﹤0.01% | 2139 |
|
|
2013
Q4 | $489K | Hold |
109,100
| – | – | ﹤0.01% | 2004 |
|
|
2013
Q3 | $443K | Sell |
109,100
-10,200
| -9% | -$41.4K | ﹤0.01% | 2005 |
|
|
2013
Q2 | $496K | Buy |
+119,300
| New | +$496K | ﹤0.01% | 1925 |
|